A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during R-CHOP in a patient with non-Hodgkin lymphoma

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 7, 2009, Pages 1199-1201

  Kondo, Mayumi ^a   Kitada, Noriaki ^a   Kobayashi, Mutsumi ^a   Morita, Satoko ^a   Yoshioka, Mutsunobu ^a   Tsuji, Takashi ^a   Mori, Ako ^a   Okamoto, Takahiro ^a   Watari, Masakatsu ^a  

^a Takarazuka Municipal Hospital   (Japan)

Author keywords

Entecavir; Hepatic injury; Non Hodgkin's lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; ENTECAVIR; LAMIVUDINE; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HEPATITIS; HEPATITIS B VIRUS; HUMAN; LIVER FUNCTION; LIVER INJURY; MALE; MEDICAL STAFF; NONHODGKIN LYMPHOMA; VIRUS REACTIVATION;

EID: 79959841439     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Sera T, Hiasa Y, Michitaka K, et al: Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 45(11): 721-724, 2006. (Pubitemid 44027603)
2. Kaplowitz N: Drug-induced liver disorders Introduction and overview. Drug Induced Liver disease (eds by Kaplowitz N and Deleve LD), Marcel Dekker, NY, 2003, pp1-13.
3. Kim JS, Hahn JS, Park SY, et al: Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma. Yonsei Med J 48(1): 78-89, 2007. (Pubitemid 46403637)